Newsroom - Page 4

What we're reading, November 26, 2015: CMS blog on step-wise transition to value-based care, payer-drug industry alliance on drug pricing, and a new model to override the proposed ACA tax credits.
Physician interest in concierge and other direct patient contracting practices is driven by frustration with reimbursement and billing hassles and a desire to spend more time with patients, but there is limited evidence on these practices' impact on cost, quality, and access to care.
The Kaiser Family Foundation Health Tracking Poll periodically gauges public opinion on important health issues. It found 56% of Americans had some connection to the painkiller epidemic and 16% knew someone who had died.
What we're reading, November 24, 2015: expensive hepatitis C drugs are more cost effective when used earlier; clinicians aren't prescribing generics enough; and half of health 45-year-olds will develop prediabetes.
The approval follows 5 months after Bristol-Myers Squibb submitted phase 3 results of the Checkmate-066 trial for FDA review.
Terms of the deal with the second-largest pharmacy benefit manager were not disclosed. Pricing for the PCSK9 inhibitor class has been a source of controversy since the cholesterol-fighting drugs were approved this summer.
Community-based organizations are ideally suited for healthcare prevention efforts and provide a needed linkage to medical care provider systems.
Two months after being granted a Breakthrough Therapy designation by the FDA for metastatic renal cell carcinoma (mRCC), nivolumab was today approved by regulators for treating mRCC patients who have failed a certain type of prior therapy.
Diabetes Compendium
Oncology Compendium